KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowNet Cash FlowNet IncomeShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

VivoSim Labs (VIVS) Capital Expenditures (2016 - 2024)

VivoSim Labs (VIVS) has 14 years of Capital Expenditures data on record, last reported at $13000.0 in Q3 2024.

  • For Q3 2024, Capital Expenditures fell 51.85% year-over-year to $13000.0; the TTM value through Dec 2025 reached $13000.0, changed 0.0%, while the annual FY2025 figure was $13000.0, 69.05% down from the prior year.
  • Capital Expenditures reached $13000.0 in Q3 2024 per VIVS's latest filing, down from $27000.0 in the prior quarter.
  • Across five years, Capital Expenditures topped out at $294000.0 in Q4 2020 and bottomed at -$356000.0 in Q1 2022.
  • Average Capital Expenditures over 5 years is $40307.7, with a median of $41000.0 recorded in 2022.
  • The widest YoY moves for Capital Expenditures: up 310.34% in 2022, down 420.72% in 2022.
  • A 5-year view of Capital Expenditures shows it stood at $294000.0 in 2020, then plummeted by 54.76% to $133000.0 in 2021, then tumbled by 69.17% to $41000.0 in 2022, then tumbled by 34.15% to $27000.0 in 2023, then plummeted by 51.85% to $13000.0 in 2024.
  • Per Business Quant database, its latest 3 readings for Capital Expenditures were $13000.0 in Q3 2024, $27000.0 in Q3 2023, and $15000.0 in Q2 2023.